文献速递耳科与耳神经

IL-1受体拮抗剂与地塞米松在噪声性听力损失中的比较:动物模型研究

Comparison of IL-1 Receptor Antagonist and Dexamethasone in Noise-Induced Hearing Loss: Animal Model.
PubMed 文献 · Otolaryngol Head Neck Surg · 2024-12-22

本研究在24只大鼠噪声性听力损失模型中比较阿那白滞素、地塞米松与对照组的疗效。第14天阿那白滞素组各频率ABR阈值优于对照组,8 kHz差异显著(P=.036),外毛细胞数显著高于对照组(P<.05)。组织学与听力学评估显示阿那白滞素与地塞米松疗效相当,作者认为阿那白滞素可能是有前景的治疗选择。

要点

  • 第14天阿那白滞素组各频率ABR阈值优于对照组,8 kHz差异显著(P=.036)。
  • 阿那白滞素组外毛细胞数显著高于对照组(P<.05)。
  • 作者认为阿那白滞素可能是有前景的噪声性听力损失治疗选择。

核心结论

  • 组织学与听力学评估显示阿那白滞素与地塞米松疗效相当,作者认为阿那白滞素可能是噪声性听力损失有前景的治疗选择。

研究设计与样本

  • 实验动物研究,在Gazi大学医学院(土耳其安卡拉)进行,24只大鼠随机分为阿那白滞素组、地塞米松组和对照组3组。
  • 所有动物暴露于宽带噪声(110 dB SPL,8小时),在噪声暴露前、暴露后即刻及第14天进行听性脑干反应(ABR)测试。
  • 阿那白滞素、地塞米松和生理盐水经腹腔注射给药,取耳蜗组织进行组织学和免疫组化评估。

主要发现

  • 第14天阿那白滞素组ABR阈值在所有频率均优于对照组,其中8 kHz差异显著(P=.036)。
  • 阿那白滞素组外毛细胞平均数量显著高于对照组(P<.05)。
  • 阿那白滞素组内毛细胞平均数量多于地塞米松组。
  • 阿那白滞素组血管纹和螺旋神经节中IL-1β免疫阳性显著高于地塞米松组(P=.022和P=.013)。
  • 对照组血管纹和螺旋神经节中TNF-α免疫阳性显著高于阿那白滞素组(P=.037和P=.01)。

临床怎么用

  • 原文未据此给出临床推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: This study aimed to attenuate cochlear inflammation following noise-induced hearing loss by targeting IL-1. We evaluated the effectiveness of IL-1 inhibition through auditory and histological assessments in an animal model. STUDY DESIGN: Experimental animal study. SETTING: Gazi University Faculty of Medicine, Ankara, Turkey. METHODS: Twenty-four rats were randomly assigned into 3 groups: Anakinra, dexamethasone, and control groups. All animals were exposed to broadband noise (110 dB SPL, 8 hours), auditory brainstem response (ABR) tests were conducted before noise exposure, immediately after, and on Day 14. Anakinra, dexamethasone, and saline were administered intraperitoneally, cochlear tissues were harvested for histological and immunohistochemical evaluation. RESULTS: On Day 14, ABR thresholds in Anakinra group were better than the control group across all frequencies, with a significant difference observed at 8 kHz (P = .036). The mean number of OHC was significantly higher in Anakinra group compared to the control group (P < .05). The mean number of IHC in the Anakinra group was greater than in the dexamethasone group. IL-1β immunopositivity in the stria vascularis and spiral ganglia was significantly higher in Anakinra group compared to dexamethasone group (P = .022 and P = .013, respectively). TNF-α immunopositivity in the stria vascularis and spiral ganglia was significantly greater in control group than in Anakinra group (P = .037 and P = .01, respectively). CONCLUSION: The comparable efficacy of Anakinra and dexamethasone in both histological and auditory assessments suggests that Anakinra may serve as a promising therapeutic option for noise-induced hearing loss.

来源:Otolaryngol Head Neck Surg,查看原文。版权归原作者所有。

引用

  1. Yaşar NG, Yiğman Z, Billur D, et al. Comparison of IL-1 Receptor Antagonist and Dexamethasone in Noise-Induced Hearing Loss: Animal Model. Otolaryngol Head Neck Surg. 2024. PMID: 39709545. doi:10.1002/ohn.1101

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。